Table 1.
Designation | Sequence 1 | IC50, nM |
---|---|---|
siRNA | 5′-GGCUUGACAAGUUGUAUAUGG-3′ 3′-AACCGAACUGUUCAACAUAUA-5′ |
3.8 ± 3.5 |
Ch-siRNA | Ch-5′-GGCUUGACAAGUUGUAUAUGG-3′ 3′-AACCGAACUGUUCAACAUAUA-5′ |
29 ± 3 |
Ch-siSCRm | Ch-5′-CAAGUCUCGUAUGUAGUGGUU-3′ 3′-UUGUUCAGAGCAUACAUCACC-5′ |
|
TsiRNA-1 | 5′-GGCUUGACAAGUUGUAUAUGGGGCUUGACAAGUUGUAUAUGGGGCUUGACAAGUUGUAUAUGG-3′ 3′-AACCGAACUGUUCAACAUAUAAACCGAACUGUUCAACAUAUAAACCGAACUGUUCAACAUAUA-5′ |
0.65 ± 0.14 |
Ch-TsiRNA-1 | Ch-5′-GGCUUGACAAGUUGUAUAUGGGGCUUGACAAGUUGUAUAUGGGGCUUGACAAGUUGUAUAUGG-3′ 3′-AACCGAACUGUUCAACAUAUAAACCGAACUGUUCAACAUAUAAACCGAACUGUUCAACAUAUA-5′ |
16 ± 10 |
TsiRNA-2 | 5′-CAGAGGCCGCUGUUCGUUUGAGCGCGAGGUCGGGAUGGAUUUGGCUUGACAAGUUGUAUAUGG-3′ 3′-UCGUCUCCGGCGACAAGCAAACUCGCGCUCCAGCCCUACCUAAACCGAACUGUUCAACAUAUA |
13 ± 7 |
Ch-TsiRNA-2 | Ch-5′-CAGAGGCCGCUGUUCGUUUGAGCGCGAGGUCGGGAUGGAUUUGGCUUGACAAGUUGUAUAUGG-3′ 3′-UCGUCUCCGGCGACAAGCAAACUCGCGCUCCAGCCCUACCUAAACCGAACUGUUCAACAUAUA–5′ |
87 ± 13 |
1 Ch—cholesterol conjugated via aminohexyl linker; 2′-O-methyl-modified nucleotides are highlighted in bold and underlined.